Literature DB >> 7399411

Purification and partial amino acid sequence of classical anaphylatoxin from pig serum: identification with Des-Arg-C5a.

B Zimmermann, B Damerau, W Vogt.   

Abstract

Complement was activated in hog serum and the biologically active peptide(s) derived from the fifth component of complement were purified. Treatment of the serum with yeast, without any precautions to inhibit serum arginine carboxypeptidase, allowed the recovery of only one active fraction, the classical anaphylatoxin; it was identified as des-Arg-C5a. When hog serum was activated with yeast in the presence of 1M epsilon-aminohexanoic acid (inhibitor of arginine carboxypeptidase), two active C5-derived fractions were obtained, C5a and des-Arg-C5a. A partial amino acid sequence of the classical anaphylatoxin (19 N-terminal and 12 C-terminal amino acids) has been elaborated. With one exception it is identical with hog C5a as far as that structure is known (12 N-, 3 C-terminal amino acids). The only difference is the C-terminal region: arginine, present in C5a, is absent from des-Arg-C5a which ends with ... Asn-Ile-Gln-Leu-Gly-OH. The finding that des-Arg-C5a, virtually free of any significant contamination with C5a, has considerable spasmogenic activity demonstrates that it is the classical anaphylatoxin, and that for spasmogenic activity arginine as the C-terminal amino acid is not absolutely essential.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7399411     DOI: 10.1515/bchm2.1980.361.1.915

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  11 in total

1.  Fast deactivation of guinea-pig isolated ileum to C5adesArg: a possible cyclic AMP-dependent mechanism.

Authors:  B Damerau; J Roesler; W Vogt
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

2.  The locomotor capacity of human lymphocytes and its enhancement by cell growth.

Authors:  P C Wilkinson
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

3.  Complement-derived polypeptide C3adesArg as a mediator of inflammation at the blood-brain barrier in a new experimental cat model.

Authors:  H G Höllerhage; G F Walter; D Stolke
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Loss and recovery of sensitivity of guinea-pig isolated ileum to the spasmogenic action of the complement peptide C5adesArg.

Authors:  B Damerau; J Roesler; W Vogt
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

5.  Pharmacological characterization of the slow component of deactivation of guinea-pig isolated ileum to the spasmogenic action of C5adesArg.

Authors:  B Damerau; J Roesler; W Vogt
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

6.  Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).

Authors:  J Sorgenfrei; B Damerau; W Vogt
Journal:  Agents Actions       Date:  1982-04

Review 7.  Activation of the complement system.

Authors:  W Vogt
Journal:  Agents Actions       Date:  1983-08

8.  Influence of the anti-inflammatory serine esterase inhibitor gabexate mesilate (Foy) on aggregation, locomotion and adhesion of polymorphonuclear leukocytes.

Authors:  B Damerau; H Wüstefeld; D Fricke; H Kunze
Journal:  Agents Actions       Date:  1984-12

9.  Comparison of adhesion to glass and aggregation of human leucocytes.

Authors:  B Damerau; H U Keller
Journal:  Agents Actions       Date:  1983-02

10.  Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.

Authors:  N A Abdullah; E S Assem; B Damerau
Journal:  Agents Actions       Date:  1988-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.